Ergonomic operator access and adequate lighting — the UCI canonical step says "make it comfortable for you the provider."
State indications for primary closure; recite the verbatim UCI contraindication list; recognize the four canonical complications.
Calculate lidocaine max — 4.5 mg/kg plain, 7 mg/kg with epi — and identify the five epi-forbidden distal-appendage sites.
1–2 L normal saline, moderate pressure, 50–100 mL per cm of wound. CHG prep, sterile drape, sterile gloves.
Sutures vs staples vs tissue adhesive — matched to location, length, tension, contamination. Simple interrupted is the workhorse.
Verbalize epi-forbidden sites pre-injection; recognize LAST prodrome (perioral numbness, tinnitus, metallic taste) and activate ASRA protocol.
Drives contamination risk and the question of whether to close at all. Bite mechanism is typically not closed primarily.
Simple < 5 cm, no gross contamination, non-LE — closable up to 12–18 h per Forsch 2017. Face shorter; LE shorter.
If you can't irrigate it clean, you can't close it primarily. Heavily contaminated → delayed primary or secondary intention.
Determines closure window, suture size, removal timing, cosmetic stakes, and which closure method is appropriate.
Deeper than mid-dermis needs layered closure (absorbable dermal + non-absorbable skin). Through fascia escalates.
Always do a distal neurovascular exam — sensation, motor, capillary refill, pulse. Exposed deep structure → do not close, escalate.
| Closure type | Indication | Window | Why |
|---|---|---|---|
| Primary intention | Clean simple laceration · edges approximate · no gross contamination | Face ≤ 6 h · trunk ≤ 12 h · scalp ≤ 24 h · simple < 5 cm non-LE ≤ 12–18 h | Best cosmetic result, fastest healing, lowest re-visit rate. |
| Delayed primary | Grossly contaminated · cannot irrigate clean today | Pack open · re-evaluate at 72–96 h | Allow inflammatory phase to declare, then close if bed is clean. |
| Secondary intention | High bacterial load · tissue loss · edges will not approximate | — | Let it close on its own — scar is worse, infection risk is lower. |
| Tissue adhesive | Low-tension · short · clean · off the face if cosmetic stakes high | Within standard golden period | Painless, fast, no removal — but not for high-tension or hair-bearing scalp. |
| Staples | Scalp · trunk · extremity (not face, not hand) | Within standard golden period | Fast, hemostatic, low infection rate; cosmetic match for scalp. |
| Method | Best for |
|---|---|
| Sutures | Most lacerations · cosmetic stakes · high-tension areas |
| Staples | Scalp · trunk · extremity (fast · hemostatic) |
| Adhesive | Short · low-tension · clean · cooperative patient |
Fast, hemostatic, cosmetically acceptable under hair. Alternative: 3-0 or 4-0 nylon. Remove at 7–10 days.
First stitch goes through the vermillion border — exact alignment matters more than anything else on the face. 1 mm off is visible at 6 months.
Close perichondrium first, then skin. Never leave cartilage exposed under skin — chondritis risk.
Plain lidocaine only (epi-forbidden). Nailbed laceration → repair with absorbable 6-0; consider hand-surgery consult.
Cat & human bites to the hand → infection risk dominates. Augmentin, escalation, often no primary closure.
Stellate, flap, avulsion — geometric closure outside bedside-APP scope. Plastics or ED attending.
Sensation, motor, capillary refill, pulse — every laceration with extremity depth gets a documented exam before closure.
If cooperation insufficient and wound is non-trivial → escalate for ED procedural sedation, not bedside force.
Perioral numbness, tinnitus, metallic taste, diplopia — any one means stop the injection, ABCs, call for help. Severe: 20% lipid emulsion 1.5 mL/kg lean body mass bolus, then infusion. Per ASRA LAST 2020.
Exposed tendon, nerve, vessel, joint capsule, bone — or any positive neurovascular finding distal to the wound — do not close. Pack moist gauze, dressing, escalate to hand surgery or plastics.
| Event | Rate | Mitigation |
|---|---|---|
| Wound infection | 1–5% | Irrigation volume · stewardship · close past golden period only when safe |
| Dehiscence | < 2% | Tension-free closure · appropriate suture size/material · accurate removal timing |
| Hypertrophic / keloid scar | variable | Patient counseling · sun protection · silicone gel · dermatology referral |
| Missed deeper injury | — | Mandatory NV exam · base inspection under anesthesia · escalate if uncertain |
| Foreign body retention | — | Direct inspection · imaging if suspected radiopaque material |
| Allergic reaction | rare | True amide allergy uncommon · preservative more often culprit · preservative-free vial |
| LAST | rare · catastrophic | Weight-based dose calc · cumulative tracking · ASRA 2020 protocol |
| Location | Days |
|---|---|
| Face | 4–5 |
| Scalp | 7–10 |
| Trunk | 7–10 |
| Upper extremity | 7–10 |
| Lower extremity | 10–14 |
| Joint-crossing | 10–14 · immobilize |
| Stage | Trigger | Scope |
|---|---|---|
| FPPE | Board approval of laceration-repair privilege | First 5 independent cases · per-case review < 14 days · aggregate at 5 |
| Case mix | FPPE pass criterion | ≥ 1 face/scalp · ≥ 1 extremity · ≥ 1 with debridement |
| OPPE | Every 6 months (TJC MS.08.01.03) | 10% sample (min 2, max 10) · 100% review on complication / return / revision |
| Reinstatement | < 5 cases over 24 mo | Bench validation + 2 proctored cases · case mix preserved |